Skip to main content

Medical Ethics, Philosophy and History of Medicine

Erasmus University Rotterdam

Erasmus MC studies the ethics of screening, euthanasia, patient choice and emerging biotechnologies while asking when health inequalities are unjust.

Research focus

The department brings historical, philosophical and empirical perspectives to clinical practice and technologies including AI, e-health, NIPT and gene editing. Its research asks how these innovations redistribute decisions and access.

Researchers

Selected reading

  1. Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider (opens in a new tab)

    Emmanuelle Lévesque et al., 2018

    Identifies consent, communication and governance questions raised when genomic risk prediction enters cancer prevention. It frames the implications for women facing risk estimates and for systems responsible for using them.

    Co-author Ineke Bolt was at Erasmus MC's Department of Medical Ethics and Philosophy of Medicine, the department's earlier name.

  2. Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda (opens in a new tab)

    Max Rensink, Ineke Bolt and Maartje Schermer, 2024

    Surveys ethical issues in forecasting when inherited neurodegenerative disease will begin or progress, from uncertainty and family relationships to decisions about testing and care. It maps questions for empirical and normative research.

    Written by scholars of Erasmus MC's Department of Medical Ethics, Philosophy and History of Medicine.

Sources

  1. Medical Ethics, Philosophy and History of Medicine, official page (opens in a new tab)
  2. Ineke Bolt, Erasmus University Rotterdam staff page (opens in a new tab)
  3. “Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider.” PubMed (opens in a new tab)
  4. “Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda.” PubMed (opens in a new tab)

The researchers above are named as part of this program’s public profile, not as directory people with a documented affiliation.

Official source reviewed .